Skip navigation
Skip navigation

Commentary: Dementia clinical trial implications of mild behavioral impairment

Mortby, Moyra; Black, Sandra; Gauthier, Serge; Miller, David S; Porsteinsson, Anton; Smith, Eric E; Ismail, Zahinoor

Description

The World Alzheimer Report 2016 estimated that 47 million people are living with dementia worldwide (Alzheimer's Disease International, 2016). In the inaugural World Health Organization Ministerial Conference on Global Action against Dementia, six of the top ten research priorities were focused on prevention, identification, and reduction of dementia risk, and on delivery and quality of care for people with dementia and their carers (Shah et al., 2016). While the Lancet Neurology Commission has...[Show more]

dc.contributor.authorMortby, Moyra
dc.contributor.authorBlack, Sandra
dc.contributor.authorGauthier, Serge
dc.contributor.authorMiller, David S
dc.contributor.authorPorsteinsson, Anton
dc.contributor.authorSmith, Eric E
dc.contributor.authorIsmail, Zahinoor
dc.date.accessioned2019-11-25T22:28:50Z
dc.identifier.issn1041-6102
dc.identifier.urihttp://hdl.handle.net/1885/186611
dc.description.abstractThe World Alzheimer Report 2016 estimated that 47 million people are living with dementia worldwide (Alzheimer's Disease International, 2016). In the inaugural World Health Organization Ministerial Conference on Global Action against Dementia, six of the top ten research priorities were focused on prevention, identification, and reduction of dementia risk, and on delivery and quality of care for people with dementia and their carers (Shah et al., 2016). While the Lancet Neurology Commission has suggested that even minor advances to delay progression or ameliorate symptoms might have substantial financial and societal benefits (Winblad et al., 2016), advances have been slow.
dc.format.extent5 pages
dc.format.mimetypeapplication/pdf
dc.language.isoen_AU
dc.publisherCambridge University Press
dc.rights© International Psychogeriatric Association 2018
dc.sourceInternational Psychogeriatrics
dc.subjectdementia
dc.subjectAlzheimer
dc.subjectclinical trial
dc.subjectrisk
dc.titleCommentary: Dementia clinical trial implications of mild behavioral impairment
dc.typeJournal article
local.description.notesImported from ARIES
local.identifier.citationvolume30
dc.date.issued2018-02-16
local.identifier.absfor111702 - Aged Health Care
local.identifier.absfor111706 - Epidemiology
local.identifier.absfor111714 - Mental Health
local.identifier.ariespublicationu4485658xPUB2249
local.publisher.urlhttps://www.cambridge.org/
local.type.statusPublished Version
local.contributor.affiliationMortby, Moyra, College of Health and Medicine, The Australian National University
local.contributor.affiliationBlack, Sandra, University of Toronto
local.contributor.affiliationGauthier, Serge, McGill Centre for Studies in Aging, Douglas Mental Health Research Institute
local.contributor.affiliationMiller, David S, Bracket Global, Wayne, PA, USA
local.contributor.affiliationPorsteinsson, Anton, University of Rochester
local.contributor.affiliationSmith, Eric E, University of Calgary
local.contributor.affiliationIsmail, Zahinoor, University of Calgary
local.description.embargo2037-12-31
local.identifier.essn1741-203X
local.bibliographicCitation.issue2
local.bibliographicCitation.startpage171
local.bibliographicCitation.lastpage175
local.identifier.doi10.1017/S1041610218000042
local.identifier.absseo920401 - Behaviour and Health
local.identifier.absseo920502 - Health Related to Ageing
local.identifier.absseo920410 - Mental Health
dc.date.updated2019-05-19T08:22:22Z
local.identifier.thomsonID000438379800002
CollectionsANU Research Publications

Download

File Description SizeFormat Image
01_Mortby_Dementia_clinical_trial_2018.pdf108.74 kBAdobe PDF    Request a copy


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator